Topic:

Infectious Diseases

Latest Headlines

Latest Headlines

First U.S. cholera vax ready for PhIII

PaxVax's single-dose oral cholera vaccine has been cleared by the U.S. FDA to go into Phase III trials. The vaccine, known as PXVX-0200, is a live, attenuated vaccine and is already available in 6 countries.

World has huge unmet vaccine needs

While vaccines in some form or another have been used since the 16th century, there are still areas of unmet need. "The world still has no vaccine for HIV/AIDS and hepatitis C, and there's need for a better vaccine against influenza," as Australian Nobel Laureate Peter Doherty told The Times of India.

GeoVax steps closer to HIV prevention

To be really effective in people at a high risk of infection, an HIV vaccine needs to protect against not just one exposure but many, and recent research from GeoVax ($GOVX) might bring this ideal type of protection a step closer.

In the clinic, Inovio's HIV vaccine treats as well as prevents

Inovio's HIV vaccine has triggered significant immune responses against a number of HIV antigens in a therapeutic clinical trial presented at the Vaccine World Summit 2012 in Hyderabad, India.

Hand, foot and mouth vaccine triggers 100% immune response

Hand, foot and mouth is a viral infection caused by a number of viruses, including the human enterovirus 71. Generally, it's just thought of as a mild infection that every now and then sweeps child care facilities and kindergartens, but it can be more sinister, and  Inviragen  has released some topline data from a Phase I trial showing an immune response from everyone receiving the vaccine.

Norovirus gets it in the nose

Call it what you like--stomach flu, gastroenteritis, tummy bug, winter vomiting virus--norovirus infections are not fun, especially on a cruise ship, and are even worse in a hospital ward. In the...

Gen X largely shrugged off call for H1N1 shots

About 2 of every 3 American adults aged 36 to 39 tracked the frenzy of reports that erupted after the swine flu pandemic broke out and concluded that there was something there that was at least...

As India nears polio eradication, researchers ponder new vaccines

Today marks the end of the first year in which India had zero reported cases of polio, a major milestone for a country that's pushed hard in recent years to eliminate the disease. Pakistan,...

FDA approves Pfizer's Prevnar 13 for adults over 50

Pfizer ($PFE) has won a much-anticipated FDA approval for Prevnar 13 for older adults to prevent pneumonia and other diseases caused by 13 Streptococcus pneumoniae serotypes contained in the vaccine....

Pfizer, GSK to provide more discount vaccines for GAVI

Pfizer ($PFE) and GlaxoSmithKline ($GSK) will provide the Global Alliance for Vaccines and Immunization (GAVI) with 360 million more pneumonia vaccines for the bargain price of $3.50 per dose....